BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28379313)

  • 1. Early sensitization of myofilaments to Ca2+ prevents genetically linked dilated cardiomyopathy in mice.
    Alves ML; Warren CM; Simon JN; Gaffin RD; Montminy EM; Wieczorek DF; Solaro RJ; Wolska BM
    Cardiovasc Res; 2017 Jul; 113(8):915-925. PubMed ID: 28379313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity.
    Rajan S; Ahmed RP; Jagatheesan G; Petrashevskaya N; Boivin GP; Urboniene D; Arteaga GM; Wolska BM; Solaro RJ; Liggett SB; Wieczorek DF
    Circ Res; 2007 Jul; 101(2):205-14. PubMed ID: 17556658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity.
    Memo M; Leung MC; Ward DG; dos Remedios C; Morimoto S; Zhang L; Ravenscroft G; McNamara E; Nowak KJ; Marston SB; Messer AE
    Cardiovasc Res; 2013 Jul; 99(1):65-73. PubMed ID: 23539503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tropomyosin-κ induces dilated cardiomyopathy and depresses cardiac myofilament tension by mechanisms involving cross-bridge dependent activation and altered tropomyosin phosphorylation.
    Karam CN; Warren CM; Rajan S; de Tombe PP; Wieczorek DF; Solaro RJ
    J Muscle Res Cell Motil; 2011 Mar; 31(5-6):315-22. PubMed ID: 21221740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin I in the murine myocardium: influence on length-dependent activation and interfilament spacing.
    Konhilas JP; Irving TC; Wolska BM; Jweied EE; Martin AF; Solaro RJ; de Tombe PP
    J Physiol; 2003 Mar; 547(Pt 3):951-61. PubMed ID: 12562915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I.
    Arteaga GM; Palmiter KA; Leiden JM; Solaro RJ
    J Physiol; 2000 Aug; 526 Pt 3(Pt 3):541-9. PubMed ID: 10922006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between alterations in length-dependent Ca2+ activation of cardiac myofilaments and the end-systolic pressure-volume relation.
    Nowak G; Peña JR; Urboniene D; Geenen DL; Solaro RJ; Wolska BM
    J Muscle Res Cell Motil; 2007; 28(7-8):415-9. PubMed ID: 18365757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.
    Parvatiyar MS; Pinto JR
    Biochim Biophys Acta; 2015 Feb; 1850(2):365-72. PubMed ID: 25450489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered signaling surrounding the C-lobe of cardiac troponin C in myofilaments containing an alpha-tropomyosin mutation linked to familial hypertrophic cardiomyopathy.
    Burkart EM; Arteaga GM; Sumandea MP; Prabhakar R; Wieczorek DF; Solaro RJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1285-93. PubMed ID: 14519438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium.
    Pi Y; Zhang D; Kemnitz KR; Wang H; Walker JW
    J Physiol; 2003 Nov; 552(Pt 3):845-57. PubMed ID: 12923217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I.
    Layland J; Cave AC; Warren C; Grieve DJ; Sparks E; Kentish JC; Solaro RJ; Shah AM
    FASEB J; 2005 Jul; 19(9):1137-9. PubMed ID: 15855227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K.
    Utter MS; Ryba DM; Li BH; Wolska BM; Solaro RJ
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):347-53. PubMed ID: 26065842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sarcomere Activators and Inhibitors Targeting Myosin Cross-Bridges on Ca
    Halas M; Langa P; Warren CM; Goldspink PH; Wolska BM; Solaro RJ
    Mol Pharmacol; 2022 May; 101(5):286-299. PubMed ID: 35236770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered hemodynamics in transgenic mice harboring mutant tropomyosin linked to hypertrophic cardiomyopathy.
    Evans CC; Pena JR; Phillips RM; Muthuchamy M; Wieczorek DF; Solaro RJ; Wolska BM
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2414-23. PubMed ID: 11045979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troponin T cardiomyopathy mutations on the calcium sensitivity of the regulated thin filament and the actomyosin cross-bridge kinetics of human β-cardiac myosin.
    Sommese RF; Nag S; Sutton S; Miller SM; Spudich JA; Ruppel KM
    PLoS One; 2013; 8(12):e83403. PubMed ID: 24367593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac troponin T mutation R141W found in dilated cardiomyopathy stabilizes the troponin T-tropomyosin interaction and causes a Ca2+ desensitization.
    Lu QW; Morimoto S; Harada K; Du CK; Takahashi-Yanaga F; Miwa Y; Sasaguri T; Ohtsuki I
    J Mol Cell Cardiol; 2003 Dec; 35(12):1421-7. PubMed ID: 14654368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
    Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
    Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated Angiogenesis Is Incompetent to Rescue Dilated Cardiomyopathy Phenotype in Mice.
    Arif M; Alam P; Ahmed RP; Pandey R; Faridi HM; Sadayappan S
    Cells; 2021 Mar; 10(4):. PubMed ID: 33807406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of a transgenic mouse model of familial dilated cardiomyopathy.
    Song W; Dyer E; Stuckey D; Leung MC; Memo M; Mansfield C; Ferenczi M; Liu K; Redwood C; Nowak K; Harding S; Clarke K; Wells D; Marston S
    J Mol Cell Cardiol; 2010 Sep; 49(3):380-9. PubMed ID: 20600154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A troponin T variant linked with pediatric dilated cardiomyopathy reduces the coupling of thin filament activation to myosin and calcium binding.
    Barrick SK; Greenberg L; Greenberg MJ
    Mol Biol Cell; 2021 Aug; 32(18):1677-1689. PubMed ID: 34161147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.